Argenx
ARGX
#578
Rank
NZ$59.60 B
Marketcap
$980.89
Share price
-3.54%
Change (1 day)
20.25%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: NZ$59.60 Billion

As of November 2024 Argenx has a market cap of NZ$59.60 Billion. This makes Argenx the world's 578th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$59.60 B67.04%
2023NZ$35.68 B8.1%
2022NZ$33.01 B22.61%
2021NZ$26.92 B38.55%
2020NZ$19.43 B90.27%
2019NZ$10.21 B95.39%
2018NZ$5.22 B85.16%
2017NZ$2.82 B
2014NZ$0.18 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Argenx was reported to be:

NZ$60.80 Billion
by Yahoo Finance info icon info icon
NZ$60.80 Billion
by CompaniesMarketCap info icon info icon
NZ$60.19 Billion
by Nasdaq info icon info icon